| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |